Los inhibidores SGLT2: una mirada al futuro del tratamiento de la insuficiencia cardiaca

• Autores: A.A. Nouel, José Luis Winter, Luis Sepúlveda
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 150, Nº. 12, 2022, págs. 1647-1654
• Idioma: español
• Títulos paralelos:
  • Sodium-glucose cotransporter 2 inhibitors for the management of heart failure
• Enlaces
  • Texto completo
• Resumen

  • Heart failure (HF) is a global health problem. There is a strong association h between HF and type 2 diabetes mellitus (DM2), with an increasing prevalence of patients having both conditions concomitantly. Sodium-glucose cotransporter 2 inhibitors (ISGLT2) significantly reduce cardiovascular events, including cardiovascular death. In this article we will focus on the current evidence about the effectiveness of these medications in adults with heart failure with reduced or preserved ejection fraction.